Results: 20
Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 361, doi. 10.1111/j.1365-2125.2005.02551.x
- Publication type:
- Article
Clinically relevant drug interactions with antiepileptic drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 246, doi. 10.1111/j.1365-2125.2005.02529.x
- By:
- Publication type:
- Article
Pharmacokinetics of a new testosterone transdermal delivery system, TDS<sup>®</sup>-testosterone in healthy males.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 275, doi. 10.1111/j.1365-2125.2005.02542.x
- By:
- Publication type:
- Article
Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 301, doi. 10.1111/j.1365-2125.2005.02545.x
- By:
- Publication type:
- Article
Author's Reply: Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Tadalafil pharmacokinetics in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 280, doi. 10.1111/j.1365-2125.2005.02553.x
- By:
- Publication type:
- Article
Disposition and pharmacodynamics of propofol during isovolaemic haemorrhage followed by crystalloid resuscitation in humans.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 256, doi. 10.1111/j.1365-2125.2005.02555.x
- By:
- Publication type:
- Article
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 309, doi. 10.1111/j.1365-2125.2005.02556.x
- By:
- Publication type:
- Article
ASCOT – old or new drugs for blood pressure?
- Published in:
- 2006
- By:
- Publication type:
- Letter
Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 315, doi. 10.1111/j.1365-2125.2005.02566.x
- By:
- Publication type:
- Article
Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 289, doi. 10.1111/j.1365-2125.2005.02567.x
- By:
- Publication type:
- Article
Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 262, doi. 10.1111/j.1365-2125.2005.02568.x
- By:
- Publication type:
- Article
Initial phase of chronic medication use; patients’ reasons for discontinuation.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 352, doi. 10.1111/j.1365-2125.2005.02569.x
- By:
- Publication type:
- Article
The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 321, doi. 10.1111/j.1365-2125.2005.02570.x
- By:
- Publication type:
- Article
Curriculum development in pharmacotherapy: testing the ability of preclinical medical students to learn therapeutic problem solving in a randomized controlled trial.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 345, doi. 10.1111/j.1365-2125.2005.02571.x
- By:
- Publication type:
- Article
Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 336, doi. 10.1111/j.1365-2125.2005.02572.x
- By:
- Publication type:
- Article
Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 326, doi. 10.1111/j.1365-2125.2005.02573.x
- By:
- Publication type:
- Article
When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 341, doi. 10.1111/j.1365-2125.2006.02577.x
- By:
- Publication type:
- Article
Orphan drug development is progressing too slowly.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 3, p. 355, doi. 10.1111/j.1365-2125.2006.02579.x
- By:
- Publication type:
- Article
Rare diseases and orphan drugs.
- Published in:
- 2006
- By:
- Publication type:
- Editorial